Advertisement
Letter to the Editor| Volume 42, e22-e23, July 2017

Download started.

Ok

Deprescription at hospital discharge: Outcomes of a deprescription promoting campaign

Published:April 18, 2017DOI:https://doi.org/10.1016/j.ejim.2017.04.008
Deprescription at hospital discharge: Outcomes of a deprescription promoting campaign
Previous ArticleRisks of contrast media applied via the gastrointestinal route
Next ArticleSerum cartilage oligomeric matrix protein levels as a novel non-invasive biomarker for liver fibrosis in patients with chronic viral hepatitis? It is too early
      Deprescription is the reduction or suspension of drugs that are not necessary or which are potentially harmful — a situation found in up to 19% of all elderly European patients and in up to 46% of all institutionalized patients. The lack of time among healthcare professionals to revise previous treatments; the incorporation of electronic prescription and its tendency to perpetuate chronic treatment; and reluctance to suspend drugs prescribed by other physicians are barriers against systematic deprescription. Hospital admission offers an opportunity to consider deprescription on a proactive basis. As a complement to the article recently published in this journal [
      • Reeve E.
      • Thompson W.
      • Farrell B.
      Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action.
      Eur J Intern Med. 2017; 38: 3-11
      ] we describe our recently reported experience [

      I. Poquet Catalá, C. Tornero Estébanez, S. Cioaia, M. Bourguet, A. Ventura Esteve, Á. Pellicer Cabo, E. Gil Tomás, M. Llopis Sanchis. Deprescripción prudente en los informes de alta hospitalaria. Resultados de una campaña de incentivación. Congreso Nacional de Medicina Interna XXXVII Congreso de la SEMI/XII Congreso de la SOMIVRAN. Zaragoza (Spain) 23–25 Noviembre 2016.

      ] with the incorporation of a deprescription promoting campaign among polymedicated patients at the time of hospital discharge.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Reeve E.
        • Thompson W.
        • Farrell B.
        Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action.
        Eur J Intern Med. 2017; 38: 3-11
        View in Article

      2. I. Poquet Catalá, C. Tornero Estébanez, S. Cioaia, M. Bourguet, A. Ventura Esteve, Á. Pellicer Cabo, E. Gil Tomás, M. Llopis Sanchis. Deprescripción prudente en los informes de alta hospitalaria. Resultados de una campaña de incentivación. Congreso Nacional de Medicina Interna XXXVII Congreso de la SEMI/XII Congreso de la SOMIVRAN. Zaragoza (Spain) 23–25 Noviembre 2016.

        View in Article
        • Garfinkel D.
        • Mangin D.
        Addressing polypharmacy: feasibility study of a systematic approach for discontinuation of multiple medications in older adults.
        Arch Intern Med. 2010; 170: 1648-1654
        View in Article
        • Van der Velde N.
        • Stricker B.H.
        • Pols H.A.
        • van der Cammen T.J.
        Risk of falls after withdrawal of fall-risk-increasing drugs: a prospective cohort study.
        Br J Clin Pharmacol. 2007; 63: 232-237
        View in Article
        • Gillespie L.D.
        • Robertson M.C.
        • Gillespie W.J.
        • Lamb S.E.
        • Gates S.
        • Cumming R.G.
        • et al.
        Interventions for preventing falls in older people living in the community.
        Cochrane Database Syst Rev. 2009; 2CD007146
        View in Article
        • Beer C.
        • Loh P.K.
        • Peng Y.G.
        • Potter K.
        • Millar A.
        A pilot randomized controlled trial of deprescribing.
        Ther Adv Drug Saf. 2011; 2: 37-43
        View in Article

      Article info

      Publication history

      Published online: April 18, 2017
      Accepted: April 12, 2017
      Received in revised form: April 11, 2017
      Received: April 7, 2017

      Identification

      DOI: https://doi.org/10.1016/j.ejim.2017.04.008

      Copyright

      © 2017 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX